In the presence of glycolysis, phosphofructokinase-1 (PFK1), a key glycolytic enzyme, could bind with TEAD1 to stabilize a PFK1-TEAD1-YAP protein complex in the nucleus, revealing a molecular mechanism for PFK1-induced tumor malignant in breast cancer [28]. Here, PFKM is linked to breast carcinoma.